Armis Advisers’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$369K Buy
4,080
+514
+14% +$41.5K 0.03% 324
2026
Q1
$278K Sell
3,566
-157
-4% -$11.8K 0.03% 369
2025
Q4
$255K Buy
+3,723
New +$295K 0.03% 361
2025
Q3
Sell
-7,976
Closed -$633K 440
2025
Q2
$633K Buy
7,976
+4,210
+112% +$325K 0.05% 247
2025
Q1
$302K Buy
3,766
+364
+11% +$30.3K 0.03% 319
2024
Q4
$279K Buy
+3,402
New +$283K 0.03% 279

Other funds holding MET

Armis Advisers's MET Position: Q2 2026 in Review

Armis Advisers increased its MetLife (MET) stake by 14% in Q2 2026, buying an estimated $41.5K and bringing the position to 4,080 shares worth $369K. The position accounts for 0.03% of the portfolio, ranked #324.

Armis Advisers first reported a position in MET in Q4 2024 and has held it in 6 quarters since. The position peaked at $633K in Q2 2025. 224 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • Armis Advisers held 4,080 shares of MetLife worth $369K as of Q2 2026.
  • Armis Advisers bought 514 MetLife shares in Q2 2026, an estimated $41.5K.
  • MetLife made up 0.03% of Armis Advisers's portfolio in Q2 2026, its #324 holding.
  • Armis Advisers first reported a position in MetLife in Q4 2024 and has held it in 6 quarters since.
  • Armis Advisers's MetLife position peaked at $633K in Q2 2025.
  • 224 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Armis Advisers's 13F filing for Q2 2026, filed 7 Jul 2026.